Section 152.25 - [Effective 12/1/2025] COMMISSIONER DUTIESSubdivision 1. [Deleted by 2023 amendment]. Subd. 1a. [Deleted by 2023 amendment]. Subd. 1b.Temporary suspension proceedings. The commissioner may institute proceedings to temporarily suspend the registration of a medical cannabis manufacturer for a period of up to 90 days by notifying the manufacturer in writing if any action by an employee, agent, officer, director, or controlling person of the manufacturer:(1) violates any of the requirements of sections 152.22 to 152.37 or the rules adopted thereunder;(2) permits, aids, or abets the commission of any violation of state law at the manufacturer's location for cultivation, harvesting, manufacturing, packaging, and processing or at any site for distribution of medical cannabis;(3) performs any act contrary to the welfare of a registered patient or registered designated caregiver; or(4) obtains, or attempts to obtain, a registration by fraudulent means or misrepresentation.Subd. 1c. [Deleted by 2023 amendment]. Subd. 2.Range of compounds and dosages; report. The office shall review and publicly report the existing medical and scientific literature regarding the range of recommended dosages for each qualifying condition and the range of chemical compositions of any plant of the genus cannabis that will likely be medically beneficial for each of the qualifying medical conditions. The office shall make this information available to patients with qualifying medical conditions beginning December 1, 2014, and update the information every three years. The office may consult with the independent laboratory under contract with the manufacturer or other experts in reporting the range of recommended dosages for each qualifying medical condition, the range of chemical compositions that will likely be medically beneficial, and any risks of noncannabis drug interactions. The office shall consult with each manufacturer on an annual basis on medical cannabis offered by the manufacturer. The list of medical cannabis offered by a manufacturer shall be published on the Office of Cannabis Management website. Subd. 3. [Deleted by 2023 amendment]. Subd. 4. [Deleted by 2023 amendment]. 2014 c 311 s 5; 2015 c 74 s 3; 2016 c 179 s 28, 29
Amended by 2024 Minn. Laws, ch. 121,s 2-15, eff. 7/1/2024.Amended by 2024 Minn. Laws, ch. 121,s 2-15, eff. 7/1/2024.Amended by 2024 Minn. Laws, ch. 85,s 41, eff. 8/1/2024.Amended by 2023 Minn. Laws, ch. 63,s 6-73, eff. 12/1/2025.Amended by 2019 Minn. Laws, ch. 9,s 11-86, eff. 8/1/2019.Amended by 2019 Minn. Laws, ch. 9,s 11-85, eff. 8/1/2019.Amended by 2019 Minn. Laws, ch. 9,s 11-84, eff. 8/1/2019.Amended by 2019 Minn. Laws, ch. 9,s 11-83, eff. 8/1/2019.Amended by 2017 Minn. Laws, ch. 6,s 10-125, eff. 5/31/2017.Amended by 2017 Minn. Laws, ch. 6,s 10-124, eff. 5/31/2017.Amended by 2017 Minn. Laws, ch. 6,s 10-123, eff. 5/31/2017.Amended by 2017 Minn. Laws, ch. 6,s 10-122, eff. 5/31/2017.Amended by 2017 Minn. Laws, ch. 40,s 1-41, eff. 8/1/2017.Amended by 2016 Minn. Laws, ch. 179,s 29, eff. 8/1/2016.Amended by 2016 Minn. Laws, ch. 179,s 28, eff. 8/1/2016.Amended by 2015 Minn. Laws, ch. 74,s 3, eff. 8/1/2015.Added by 2014 Minn. Laws, ch. 311,s 5, eff. 5/30/2014.This section is set out more than once due to postponed, multiple, or conflicting amendments.